Risk & Weakness
Weakness Cluster
Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Market filter active: the list shows 100 hits from US
Stage 4 + very weak RS (≤ 15) + price below the 200-day SMA — multiple weakness signals bundled together.
Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); fundamentally healthy names (Piotroski ≥ 5 or Fundamental Rating ≥ 55 out of 100) are excluded.
🔔 Watch scanner
Terms in This Scanner Explained
(17)
- ADR (Average Daily Range)
- The average daily swing of a stock in percent - measured over 10 or 30 trading days (columns "ADR 10D/30D"). An ADR of 5% means: on a normal day the gap between the intraday low and high runs about 5%. Traders look for movement - that is why stocks with an ADR under 1% are filtered out globally. Not to be confused with ADR meaning "American Depositary Receipt" (a US certificate for foreign shares) - here ADR always means the daily swing.
- AI Classification
- Our company-by-company assessment of the AI boom based on SEC filings (the last four quarterly 10-Q reports and two annual 10-K reports): "Sells AI" (AI is a revenue source), "Threatened" (AI is a concrete business risk), "Uses AI" (operational use), or "Neutral" (no material AI exposure). Every classification requires at least two direct quote citations - otherwise the column shows "-". Not a quality judgment or a buy recommendation; the full file is on the stock page, methodology at /stocks/ai-rating-methodology.
- Analysis (Full Company Analysis)
- If the Analysis column shows "Read," there is an in-depth TickerGuard company analysis for this stock: business model, scanner findings, quarterly results, evidence from SEC filings, plus opportunities and risks. One click opens it directly.
- Avg/Yr 3Y (Average Annual Return)
- The stock's average annual return over the past 3 years. Shows at a glance whether a stock delivers over the long run or just had a short hot streak.
- Earnings Date
- The date of the next quarterly earnings report. Price gaps in either direction are common around this date - that is why we color it red when it is 7 days away or less, and yellow when it is 14 days away or less: elevated risk for fresh positions.
- EPS (Earnings per Share)
- Quarterly earnings divided by the number of shares outstanding. The most important growth metric: if EPS rises strongly over several quarters, the company is earning more money per share.
- Free Cash Flow (FCF)
- Operating cash flow minus capital expenditures - the money left over for everything else (debt paydown, acquisitions, or buybacks). Consistently positive free cash flow is one of the most honest signs of a healthy business model.
- Funda Rating (Fundamental Rating A+ to F)
- Our proprietary fundamental rating from 0 to 100 points with a school-grade rank from A+ to F. 50 points is the average across the universe, 100 the best possible score. Every stock is scored against all others by percentile: growth in earnings and revenue, earnings surprises, analyst estimates, and quality criteria such as margins, cash flow, and balance-sheet strength. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below — A/A+ are the fundamentally strongest stocks in the universe.
- Market Capitalization (Mkt Cap)
- The market value of the company: share price x total shares outstanding, shown here in billions of dollars. Micro caps (< $0.3B) are small and volatile, mega caps (> $200B) are heavyweights. Our scanner universe is deliberately capped at $50B - we look for stocks with room to run.
- Net Margin
- How much of revenue is left as profit? Net income divided by revenue, in percent. A 20% margin means: out of every dollar of revenue, 20 cents is left as profit. Rising margins are a strong quality signal.
- Operating Cash Flow (OCF)
- The cash that actually flows into the company from day-to-day operations - without accounting effects such as depreciation. A company can report book profits while still burning cash; operating cash flow reveals that.
- Piotroski F-Score
- A balance-sheet health check developed by Joseph Piotroski: 9 yes/no criteria covering earnings, cash flow, leverage, and efficiency produce a score from 0 to 9. Scores of 7 or higher are considered financially very solid, scores under 3 a warning sign.
- Relative Strength (RS Rating)
- How much has a stock risen compared with every other stock? The RS Rating is a percentile from 1 to 99: RS 90 means the stock has outperformed 90% of all stocks (depending on the scanner, over 1 week, 1, 3, 6, or 12 months). Market leaders almost always carry high RS values - that is why relative strength is the core of many momentum strategies.
- Sector & Industry
- Two levels of industry classification: sector is broad (e.g., Technology), industry is narrow (e.g., Semiconductors). Many strategies watch industry strength, because strong stocks are almost always found in strong industries.
- SMA / Moving Average (10-, 20-, 50-, 200-Day Line)
- The average price of the last X days, plotted as a line on the chart (Simple Moving Average). The 50-day and 200-day lines are the most closely watched: price above the line = uptrend intact. The 30-week line from the Weinstein method corresponds to the 150-day line.
- Stage (Weinstein Stages 1-4)
- Stan Weinstein divides every price chart into four stages: Stage 1 = basing (sideways after a downtrend), Stage 2 = uptrend (the only buying stage), Stage 3 = topping, Stage 4 = downtrend (avoid, or short candidate). Measured against the 30-week line (150-day moving average) and its slope.
- Stress RS (Strength on Stress Days)
- A stress day is a day on which both the overall market and the stock's own sector fell at least 0.5%. Stress RS counts on how many of these days the stock still closed green (shown as "g/n" = green days out of n stress days) and turns that into a rating from 1 to 99. High values point to buyers stepping in even on weak days - often a sign of institutional accumulation.
Hit List
Filter ▾
Rating (traffic light)
Stage
Funda Rating
Piotroski
Columns ▾
This scanner's columns
Extra columns
Tip: clicking a column header sorts the table by that column; a second click flips the direction.
| Symbol | Earnings | Avg/Y 3Y | Stress RS | Stage | Funda Rating | Piotroski | MktCap | Industry | AI Rating | Deep Dive | Deep-Dive Report | Sector | Price | YTD | 6 Mo. | 1 Year | Off High | Price Target | RS | EPS Rating | ADR 10D | ADR 30D | Beta | P/E | P/E (f) | P/S | P/B | P/FCF | PEG | EV/EBITDA | EBIT Margin | Gross Margin | Net Margin | ROE | ROA | Debt/Eq | Equity Ratio | Sales +/Y | Growth Score | Div. Yield | Payout Ratio | Altman Z | Inst. % | Short % | Analysts |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| STEP Stepstone Group Inc | 08/06 | +34 % | 54 5/22 | Stage 4 | C 54 | 4 of 9 | 5.9 $ | Asset Management | – | — | — | Financial Services | 43.90 $ | -31.4 % | -37.4 % | -23.6 % | −47.4 % | +51.5 % | 15 | 18 | 6.2 % | 5.7 % | 1.30 | — | 18.1 | 2.9 | — | 91.8 | — | 16.5 | -3.5 % | -41.9 % | -26.9 % | -55.9 % | -11.3 % | — | -6.1 % | +69.7 % | 3 | 3.8 % | 94.9 % | 3.0 | 103.3 % | 10.0 % | 3.8 (6) |
| PSN Parsons Corp | 08/05 | +1 % | 19 3/25 | Stage 4 | D 43 | 3 of 9 | 4.7 $ | Information Technology Services | – | — | — | Technology | 44.20 $ | -20.3 % | -18.3 % | -40.4 % | −47.4 % | +36.0 % | 15 | 24 | 5.0 % | 4.5 % | 0.66 | 22.9 | 14.7 | 0.8 | 1.9 | 11.3 | — | 13.0 | 6.3 % | 22.0 % | 2.5 % | 11.0 % | 3.6 % | 0.63 | 44.1 % | -5.7 % | 5 | 0.0 % | 0.0 % | 6.2 | 101.9 % | 15.3 % | 3.8 (11) |
| ROCK Gibraltar Industries Inc | 08/05 | -11 % | 23 4/29 | Stage 4 | D 38 | 2 of 9 | 1.3 $ | Building Products & Equipment | – | — | — | Industrials | 42.30 $ | -20.5 % | -10.9 % | -36.0 % | −41.1 % | +71.4 % | 15 | 24 | 4.9 % | 4.7 % | 1.21 | 20.2 | 11.1 | 1.1 | 1.4 | 17.9 | 0.74 | 20.3 | 6.1 % | 26.1 % | -10.7 % | 6.6 % | 3.9 % | 1.56 | 31.6 % | -13.2 % | 4 | 0.0 % | 0.0 % | 5.3 | 107.5 % | 7.6 % | 4.7 (3) |
| CRAI CRA International Inc | 07/30 | +17 % | 76 9/29 | Stage 4 | C 48 | 2 of 9 | 1.1 $ | Consulting Services | – | — | — | Industrials | 179.00 $ | -27.7 % | -30.3 % | +2.7 % | −37.1 % | +41.1 % | 15 | 18 | 4.5 % | 4.4 % | 0.68 | 25.4 | 21.0 | 1.5 | 6.0 | — | 1.31 | 13.4 | — | 29.4 % | 6.2 % | 22.5 % | 7.5 % | 1.41 | — | +9.3 % | 4 | 1.3 % | 36.0 % | 4.8 | 88.1 % | 4.7 % | 3.5 (2) |
| CLB Core Laboratories NV | 07/22 | -16 % | 29 1/10 | Stage 4 | C 46 | 4 of 9 | 0.5 $ | Oil & Gas Equipment & Services | – | — | — | Energy | 10.60 $ | -27.3 % | -33.9 % | -2.5 % | −46.4 % | +46.2 % | 15 | 20 | 4.7 % | 4.6 % | 1.01 | 17.5 | 19.8 | 0.9 | 1.8 | 41.0 | 1.67 | 10.1 | — | 19.5 % | 4.7 % | 11.1 % | 4.5 % | 0.62 | — | +0.5 % | 4 | 0.4 % | 6.7 % | 6.9 | 113.7 % | 20.8 % | 3.0 (5) |
| OPTU Optimum Communications, Inc. | 08/06 | -12 % | — | Stage 4 | D 28 | 4 of 9 | 0.0 $ | Telecom Services | – | — | — | Communication Services | 0.76 $ | -18.2 % | -10.6 % | -70.7 % | −46.3 % | -25.7 % | 15 | 50 | 13.6 % | 16.5 % | 1.15 | — | 28.2 | — | 28.8 | — | 1.06 | 16.7 | — | 69.5 % | -55.0 % | 0.0 % | 3.3 % | -5.13 | — | -4.1 % | 3 | 0.0 % | 0.0 % | 2.1 | 102.3 % | 45.1 % | — |
| SHOE Shoe Station Group Inc. | — | -9 % | — | Stage 4 | D 37 | 3 of 9 | 0.0 $ | Apparel Retail | – | — | — | Consumer Cyclical | 15.20 $ | -8.0 % | -13.5 % | -22.9 % | −41.2 % | +40.8 % | 15 | 50 | 5.0 % | 4.8 % | 1.42 | — | 10.1 | — | — | — | — | 7.3 | — | 36.3 % | 3.3 % | 5.6 % | 3.4 % | — | — | -5.6 % | 3 | 4.2 % | 35.8 % | 9.7 | 74.3 % | 17.7 % | — |
| KROS Keros Therapeutics Inc | 08/05 | -25 % | 2 0/22 | Stage 4 | D 33 | 3 of 9 | 0.2 $ | Biotechnology | – | — | — | Healthcare | 10.10 $ | -46.0 % | -48.8 % | -29.7 % | −53.8 % | +109.7 % | 15 | 42 | 4.9 % | 5.1 % | 0.97 | — | 48.8 | 6.1 | — | — | — | -13.0 | — | -184.9 % | -256.6 % | -16.8 % | -12.2 % | — | — | +6,775.0 % | — | 0.0 % | 0.0 % | 13.1 | 96.2 % | 8.2 % | — |
| HDSN Hudson Technologies Inc | 07/29 | -13 % | 22 3/23 | Stage 4 | D 41 | 4 of 9 | 0.2 $ | Specialty Chemicals | – | — | — | Basic Materials | 6.00 $ | -15.9 % | -21.3 % | -35.7 % | −47.1 % | +52.6 % | 15 | 5 | 3.9 % | 4.1 % | 0.78 | 18.7 | 14.3 | 1.0 | 1.1 | — | 0.39 | 10.3 | — | 24.6 % | 5.7 % | 5.9 % | 4.3 % | 0.02 | — | +4.0 % | — | 0.0 % | 0.0 % | 11.9 | 81.3 % | 4.0 % | — |
| SIGA SIGA Technologies Inc | 08/04 | +4 % | 15 2/22 | Stage 4 | D 40 | 0 of 9 | 0.2 $ | Drug Manufacturers - Specialty & Generic | – | — | — | Healthcare | 3.30 $ | -20.4 % | -34.9 % | -44.1 % | −58.9 % | +343.8 % | 15 | 98 | 4.1 % | 3.6 % | 0.89 | 11.8 | 27.5 | 2.6 | 1.6 | 8.7 | 3.37 | 6.2 | — | 43.6 % | 21.6 % | 11.0 % | 5.5 % | 0.00 | — | -31.8 % | — | 9.5 % | 2.2 % | 9.5 | 49.9 % | 7.4 % | — |
| RR Richtech Robotics Inc. Class B Common Stock | 07/01 | — | 37 5/29 | Stage 4 | D 44 | 4 of 9 | 0.3 $ | Specialty Industrial Machinery | – | — | — | Industrials | 1.40 $ | -37.5 % | -45.8 % | -25.3 % | −74.6 % | +111.6 % | 15 | 42 | 7.4 % | 9.5 % | -0.85 | — | 0.0 | 63.7 | 0.9 | — | — | 0.0 | — | 55.8 % | 0.0 % | -10.6 % | -8.1 % | 0.00 | — | +19.0 % | — | 0.0 % | 0.0 % | 45.2 | 40.4 % | 27.4 % | — |
| SERA Sera Prognostics Inc | 08/05 | -31 % | 58 5/22 | Stage 4 | D 32 | 2 of 9 | 0.1 $ | Medical Devices | – | — | — | Healthcare | 2.00 $ | -37.6 % | -49.7 % | -26.6 % | −56.0 % | +205.6 % | 15 | 42 | 6.5 % | 9.2 % | 0.97 | — | 0.0 | — | 1.2 | — | — | -0.6 | — | -191.2 % | 0.0 % | -39.6 % | -21.6 % | 0.04 | — | +5.2 % | — | 0.0 % | 0.0 % | -5.6 | 63.1 % | 0.9 % | — |
| GPK Graphic Packaging Holding Company | 08/04 | -18 % | 32 5/31 | Stage 4 | D 39 | 3 of 9 | 3.1 $ | Packaging & Containers | – | — | — | Consumer Cyclical | 10.70 $ | -30.6 % | -28.0 % | -50.4 % | −54.1 % | +10.3 % | 14 | 15 | 4.2 % | 4.6 % | 0.68 | — | 13.9 | 0.4 | — | 20.4 | 3.33 | 7.6 | 4.1 % | 17.0 % | 3.2 % | 8.6 % | 3.8 % | — | 27.8 % | -2.2 % | 2 | 4.1 % | 45.8 % | 4.9 | 117.7 % | 10.9 % | 2.9 (10) |
| YELP Yelp Inc | 08/06 | -12 % | 75 7/24 | Stage 4 | C 52 | 4 of 9 | 1.4 $ | Internet Content & Information | – | — | — | Communication Services | 26.40 $ | -25.4 % | -20.0 % | -23.2 % | −36.3 % | +1.2 % | 14 | 24 | 4.5 % | 4.8 % | 0.46 | — | 14.7 | 1.0 | — | 5.1 | 0.40 | 6.1 | 9.0 % | 90.0 % | 9.5 % | 20.5 % | 11.6 % | — | 62.3 % | +3.8 % | 5 | 0.0 % | 0.0 % | 2.7 | 116.7 % | 27.0 % | 3.0 (12) |
| RXRX Recursion Pharmaceuticals Inc | 08/04 | -19 % | 2 0/22 | Stage 4 | C 46 | 4 of 9 | 1.6 $ | Biotechnology | Sells AI | — | Healthcare | 3.00 $ | -22.7 % | -16.1 % | -49.6 % | −53.5 % | +141.7 % | 14 | 42 | 6.8 % | 7.9 % | 1.00 | — | 0.0 | 24.1 | — | — | — | -5.3 | — | -645.6 % | 0.0 % | -57.2 % | -27.7 % | — | — | +26.9 % | 3 | 0.0 % | 0.0 % | 1.3 | 68.8 % | 36.1 % | 3.4 (8) | |
| AVD American Vanguard Corporation | 07/30 | -28 % | 76 7/23 | Stage 4 | D 35 | 4 of 9 | 0.1 $ | Agricultural Inputs | – | — | — | Basic Materials | 2.40 $ | -33.0 % | -31.9 % | -38.1 % | −54.4 % | +344.4 % | 14 | 24 | 7.9 % | 7.6 % | 1.42 | — | 15.5 | 0.1 | — | — | 0.25 | 67.2 | — | 29.8 % | -8.7 % | -21.9 % | 1.1 % | — | — | -5.9 % | — | 0.0 % | 0.0 % | 6.7 | 67.6 % | 3.0 % | — |
| MDWD Mediwound Ltd | 08/13 | +12 % | 41 4/22 | Stage 4 | D 31 | 2 of 9 | 0.2 $ | Biotechnology | – | — | — | Healthcare | 14.20 $ | -23.8 % | -20.1 % | -24.3 % | −31.4 % | +106.8 % | 14 | 42 | 3.6 % | 4.3 % | 0.15 | — | 35.0 | 13.2 | 4.4 | — | — | -6.3 | — | 19.6 % | -180.3 % | -71.8 % | -23.5 % | 0.20 | — | -16.1 % | — | 0.0 % | 0.0 % | — | 58.2 % | 15.0 % | — |
| MGX Metagenomi, Inc. Common Stock | 08/11 | — | 7 1/22 | Stage 4 | D 37 | 3 of 9 | 0.0 $ | Biotechnology | Uses AI | — | — | Healthcare | 1.20 $ | -23.5 % | -31.0 % | -48.3 % | −69.9 % | +572.3 % | 14 | 42 | 6.5 % | 5.4 % | 0.70 | — | 0.0 | 2.2 | 0.3 | — | — | 0.0 | — | -321.0 % | 0.0 % | -49.0 % | -23.4 % | 0.28 | — | -51.8 % | — | 0.0 % | 0.0 % | 1.3 | 19.3 % | 5.8 % | — |
| SNTI Senti Biosciences Inc | 08/06 | -33 % | 89 8/22 | Stage 4 | C 47 | 3 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 0.34 $ | -11.1 % | -3.5 % | -79.9 % | −62.9 % | +1,115.0 % | 14 | 42 | 7.4 % | 6.9 % | 2.05 | — | 0.0 | — | 4.1 | — | — | -0.3 | — | -98,897.4 % | 0.0 % | -255.0 % | -56.9 % | 7.46 | — | -100.0 % | 3 | 0.0 % | 0.0 % | -36.6 | 18.5 % | 3.6 % | — |
| BLDR Builders FirstSource Inc | 07/30 | -13 % | 1 0/29 | Stage 4 | D 37 | 3 of 9 | 7.1 $ | Building Products & Equipment | – | — | — | Industrials | 66.40 $ | -25.4 % | -13.0 % | -47.7 % | −41.3 % | +21.9 % | 13 | 5 | 6.2 % | 5.4 % | 1.42 | 25.5 | 16.2 | 0.5 | 1.8 | 11.2 | 2.02 | 11.9 | 0.5 % | 29.2 % | 0.7 % | 7.0 % | 2.4 % | -39.00 | 35.4 % | -7.4 % | 2 | 0.0 % | 0.0 % | 5.0 | 101.9 % | 8.0 % | 4.3 (21) |
| ACI Albertsons Companies | 07/21 | -10 % | 90 6/16 | Stage 4 | D 39 | 4 of 9 | 5.8 $ | Grocery Stores | – | — | — | Consumer Defensive | 11.60 $ | -17.4 % | -20.6 % | -37.2 % | −39.6 % | +25.0 % | 13 | 23 | 4.1 % | 3.5 % | 0.25 | 30.0 | 6.2 | 0.1 | 3.1 | 2.8 | 1.24 | 6.5 | 1.7 % | 27.0 % | 0.1 % | 8.3 % | 3.9 % | 24.08 | 6.9 % | +3.5 % | 4 | 5.9 % | 31.8 % | 3.4 | 99.9 % | 15.3 % | 3.8 (21) |
| AI C3 Ai Inc | — | -24 % | 34 4/25 | Stage 4 | D 29 | 1 of 9 | 1.3 $ | Software - Infrastructure | – | — | — | Technology | 9.20 $ | -28.2 % | -36.8 % | -61.0 % | −70.9 % | -4.1 % | 13 | 42 | 6.0 % | 6.7 % | 2.05 | — | 0.0 | 5.4 | 2.3 | — | — | -2.3 | — | 30.9 % | -188.0 % | -63.1 % | -33.1 % | — | — | -35.7 % | 2 | 0.0 % | 0.0 % | 1.1 | 63.9 % | 31.1 % | 2.9 (15) |
| MGPI MGP Ingredients Inc | 07/30 | -27 % | 29 2/16 | Stage 4 | D 43 | 3 of 9 | 0.4 $ | Beverages - Wineries & Distilleries | – | — | — | Consumer Defensive | 17.70 $ | -29.5 % | -30.0 % | -36.0 % | −51.0 % | +58.2 % | 13 | 19 | 3.9 % | 3.6 % | 0.46 | — | 13.3 | 0.7 | 0.7 | 6.8 | 1.13 | 19.2 | — | 35.6 % | -48.4 % | -34.1 % | 3.4 % | 0.44 | — | -23.8 % | — | 2.7 % | 20.4 % | 5.9 | 73.3 % | 6.5 % | 4.5 (6) |
| CTGO Contango ORE Inc | 08/12 | -12 % | 22 3/23 | Stage 4 | D 30 | 4 of 9 | 0.5 $ | Gold | – | — | — | Basic Materials | 15.40 $ | -40.8 % | -46.5 % | -17.4 % | −56.6 % | +115.4 % | 13 | 42 | 6.5 % | 6.7 % | -0.02 | — | 1.9 | — | 1.6 | — | — | 34.2 | — | — | 0.0 % | -18.5 % | -0.7 % | 0.10 | — | — | 5 | 0.0 % | 0.0 % | 3.7 | 36.8 % | 8.8 % | 4.2 (5) |
| DOUG Douglas Elliman Inc | 07/30 | -7 % | 63 5/21 | Stage 4 | C 53 | 3 of 9 | 0.2 $ | Real Estate Services | – | — | — | Real Estate | 1.70 $ | -27.0 % | -26.2 % | -38.6 % | −44.8 % | +81.8 % | 13 | 7 | 3.9 % | 4.4 % | 1.89 | 33.6 | 0.0 | 0.2 | 0.9 | — | — | 9.2 | — | 100.0 % | 0.5 % | 2.7 % | -3.0 % | 0.61 | — | +3.8 % | — | 0.0 % | 0.0 % | 5.1 | 50.8 % | 2.5 % | — |
| HHS Harte Hanks Inc | 08/06 | -19 % | 49 6/29 | Stage 4 | D 30 | 3 of 9 | 0.0 $ | Conglomerates | – | — | — | Industrials | 2.30 $ | -20.3 % | -32.9 % | -35.8 % | −46.4 % | +629.2 % | 13 | 4 | 4.3 % | 3.2 % | -0.02 | — | 5.7 | 0.1 | 0.9 | — | 0.47 | 5.4 | — | 16.8 % | -0.7 % | -5.0 % | -0.3 % | 1.10 | — | -13.9 % | 4 | 0.0 % | 0.0 % | 33.9 | 31.3 % | 0.5 % | — |
| TCRX Tscan Therapeutics Inc | 08/11 | -22 % | 7 1/22 | Stage 4 | D 28 | 2 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 0.74 $ | -7.9 % | -6.0 % | -57.3 % | −67.3 % | +614.3 % | 13 | 42 | 10.4 % | 7.8 % | 1.04 | — | 0.0 | 5.2 | 0.5 | — | — | 0.4 | — | -1,045.6 % | 0.0 % | -81.0 % | -29.6 % | 0.96 | — | +266.7 % | — | 0.0 % | 0.0 % | -4.8 | 59.5 % | 1.7 % | — |
| CPNG Coupang LLC | 08/04 | +2 % | 51 7/31 | Stage 4 | C 50 | 3 of 9 | 29.1 $ | Internet Retail | – | — | — | Consumer Cyclical | 16.40 $ | -25.8 % | -22.9 % | -44.4 % | −49.9 % | +57.5 % | 12 | 70 | 5.2 % | 5.2 % | 1.11 | — | 35.3 | 0.8 | 7.8 | 95.9 | 0.45 | 38.4 | -2.9 % | 28.8 % | -0.5 % | -4.0 % | 0.4 % | 1.23 | 22.6 % | +14.1 % | 6 | 0.0 % | 0.0 % | 2.7 | 88.1 % | 6.3 % | 4.2 (17) |
| BRO Brown & Brown Inc | 07/27 | -2 % | 88 8/22 | Stage 4 | C 53 | 2 of 9 | 23.9 $ | Insurance Brokers | – | — | — | Financial Services | 70.40 $ | -23.8 % | -20.4 % | -22.3 % | −45.2 % | +7.5 % | 12 | 28 | 2.9 % | 3.2 % | 0.60 | 24.2 | 15.4 | 3.5 | 1.9 | 16.0 | 1.51 | 12.4 | 47.2 % | 56.3 % | 18.1 % | 11.9 % | 5.4 % | -3.24 | 42.4 % | +26.6 % | 5 | 0.9 % | 14.9 % | 5.3 | 86.8 % | 7.3 % | 3.6 (12) |
| RYAN Ryan Specialty Group Holdings Inc | 07/30 | -6 % | 79 7/22 | Stage 4 | C 51 | 4 of 9 | 11.6 $ | Insurance - Specialty | – | — | — | Financial Services | 44.20 $ | -32.7 % | -24.0 % | -27.0 % | −48.1 % | +11.2 % | 12 | 87 | 4.7 % | 4.8 % | 0.60 | 54.4 | 21.3 | 3.6 | 8.8 | 22.7 | — | 0.0 | 17.4 % | 41.5 % | 3.1 % | 22.8 % | 3.5 % | 5.88 | 5.8 % | +21.3 % | 5 | 1.2 % | 23.9 % | 3.7 | 89.1 % | 14.9 % | 3.9 (13) |
| GT Goodyear Tire & Rubber Co | 08/06 | -18 % | 33 5/31 | Stage 4 | D 32 | 2 of 9 | 2.0 $ | Auto Parts | – | — | — | Consumer Cyclical | 7.00 $ | -32.6 % | -23.9 % | -32.4 % | −45.4 % | +6.5 % | 12 | 73 | 5.5 % | 4.4 % | 1.12 | — | 7.9 | 0.1 | 0.7 | — | 0.43 | 9.4 | 0.2 % | 18.6 % | -11.6 % | -50.0 % | 0.9 % | 2.67 | 16.3 % | -3.2 % | 4 | 0.0 % | 0.0 % | 4.1 | 96.4 % | 17.3 % | 3.9 (9) |
| ASST Strive Asset Management | 08/04 | -33 % | 55 5/22 | Stage 4 | D 40 | 3 of 9 | 1.0 $ | Asset Management | – | — | — | Financial Services | 11.10 $ | -5.5 % | -32.6 % | -83.3 % | −42.3 % | +161.3 % | 12 | 42 | 9.8 % | 9.0 % | 13.21 | — | 0.9 | 131.9 | 1.3 | — | — | -2.3 | — | -535.7 % | 0.0 % | -125.4 % | -62.6 % | 0.01 | — | +57.1 % | 4 | 0.0 % | 0.0 % | 44.2 | 47.7 % | 30.4 % | — |
| UTZ Utz Brands Inc | 07/30 | -18 % | 47 3/16 | Stage 4 | D 30 | 2 of 9 | 1.2 $ | Packaged Foods | Neutral | — | Consumer Defensive | 14.10 $ | -30.9 % | -22.9 % | +11.5 % | −50.8 % | +1.5 % | 12 | 15 | 4.4 % | 4.1 % | 0.83 | — | 18.2 | 0.8 | 1.8 | 28.8 | — | 18.6 | — | 25.4 % | -0.6 % | -1.2 % | 0.3 % | 0.07 | — | +2.1 % | 4 | 1.8 % | 30.9 % | 3.6 | 85.9 % | 11.5 % | 4.2 (11) | |
| PSFE Paysafe Ltd | 08/11 | -13 % | 47 5/25 | Stage 4 | D 40 | 4 of 9 | 0.4 $ | Software - Infrastructure | Uses AI | — | Technology | 8.10 $ | -19.0 % | -10.4 % | -33.5 % | −55.9 % | +21.9 % | 12 | 42 | 5.5 % | 5.8 % | 1.75 | — | 3.6 | 0.2 | 0.7 | 2.5 | — | 8.0 | — | 56.4 % | -11.4 % | -27.0 % | 1.6 % | 4.11 | — | -0.2 % | — | 0.0 % | 0.0 % | 2.1 | 59.4 % | 13.2 % | 3.0 (7) | |
| QSI QuantumSi Inc | 08/04 | -25 % | 17 2/22 | Stage 4 | D 40 | 1 of 9 | 0.2 $ | Medical Devices | – | — | — | Healthcare | 0.71 $ | -20.0 % | -32.1 % | -51.9 % | −72.4 % | +190.7 % | 12 | 42 | 9.5 % | 9.4 % | 3.20 | — | 0.0 | 77.0 | 0.7 | — | — | 0.6 | — | 40.0 % | 0.0 % | -46.4 % | -24.8 % | 0.02 | — | -20.3 % | — | 0.0 % | 0.0 % | 9.5 | 29.9 % | 12.7 % | — |
| MYPS Playstudios Inc | 08/03 | -30 % | 84 8/24 | Stage 4 | D 44 | 4 of 9 | 0.1 $ | Electronic Gaming & Multimedia | Neutral | — | Communication Services | 0.61 $ | -21.0 % | -27.7 % | -47.4 % | −68.6 % | +13.6 % | 12 | 53 | 13.3 % | 13.0 % | 0.96 | — | 208.3 | 0.4 | 0.4 | 2.8 | 7.00 | 0.4 | — | 76.7 % | -15.8 % | -15.7 % | -5.8 % | 0.03 | — | -18.8 % | — | 0.0 % | 0.0 % | 7.3 | 37.9 % | 1.8 % | — | |
| ARQ Arq Inc | 08/10 | +10 % | 67 8/29 | Stage 4 | C 48 | 4 of 9 | 0.1 $ | Pollution & Treatment Controls | – | — | — | Industrials | 2.00 $ | -24.8 % | -26.7 % | -63.2 % | −71.1 % | +70.0 % | 12 | 42 | 7.3 % | 5.7 % | 2.79 | — | 64.9 | 0.7 | — | — | 11.75 | 11.3 | — | 31.8 % | -43.9 % | -27.8 % | -2.4 % | — | — | +10.4 % | — | 0.0 % | 0.0 % | 4.7 | 35.5 % | 4.1 % | — |
| ATNM Actinium Pharmaceuticals Inc | 08/14 | -29 % | 70 6/22 | Stage 4 | D 42 | 2 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 0.84 $ | -25.0 % | -37.7 % | -48.7 % | −49.7 % | +426.3 % | 12 | 42 | 5.1 % | 5.7 % | -0.02 | — | 6.8 | 250.0 | 11.4 | — | — | -3.6 | — | 100.0 % | 0.0 % | -167.7 % | -28.0 % | 0.66 | — | -100.0 % | 3 | 0.0 % | 0.0 % | -24.8 | 20.6 % | 3.0 % | — |
| EP Empire Petroleum Corp | 08/12 | -23 % | 98 5/10 | Stage 4 | E 16 | 4 of 9 | 0.1 $ | Oil & Gas E&P | – | — | — | Energy | 2.50 $ | -9.5 % | -11.8 % | -44.9 % | −56.1 % | — | 12 | 42 | 6.9 % | 7.2 % | 0.28 | — | 0.0 | 3.0 | 26.5 | — | — | 61.6 | — | 17.1 % | -226.5 % | -237.4 % | -45.2 % | 4.14 | — | -22.3 % | — | 0.0 % | 0.0 % | -10.6 | 8.2 % | 0.0 % | — |
| OWLT Owlet Inc | 08/06 | +3 % | 16 2/22 | Stage 4 | D 40 | 3 of 9 | 0.1 $ | Medical Devices | – | — | — | Healthcare | 5.20 $ | -67.4 % | -62.5 % | -29.6 % | −68.5 % | +143.4 % | 12 | 42 | 9.0 % | 7.4 % | 1.84 | — | 0.0 | 1.4 | — | — | — | -0.6 | — | 50.9 % | -43.0 % | -526.2 % | -10.0 % | — | — | +35.4 % | — | 0.0 % | 0.0 % | -8.5 | 74.4 % | 2.4 % | — |
| RNTX Rein Therapeutics Inc | 08/13 | -25 % | 58 5/22 | Stage 4 | D 30 | 2 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 0.74 $ | -16.5 % | -21.2 % | -36.7 % | −57.1 % | +751.1 % | 12 | 42 | 8.9 % | 8.4 % | 1.35 | — | 0.0 | — | — | — | — | -0.6 | — | — | 0.0 % | -163.4 % | -32.1 % | — | — | — | — | 0.0 % | 0.0 % | -60.0 | 24.6 % | 0.4 % | — |
| PRIM Primoris Services Corporation | 08/03 | +67 % | 36 5/29 | Stage 4 | C 51 | 3 of 9 | 5.8 $ | Engineering & Construction | – | — | — | Industrials | 84.40 $ | -31.5 % | -24.8 % | -10.1 % | −53.6 % | +51.1 % | 11 | 12 | 10.3 % | 8.2 % | 1.42 | 18.2 | 40.3 | 0.8 | 2.6 | 35.6 | 1.22 | 11.2 | 1.8 % | 10.4 % | 3.3 % | 15.9 % | 5.5 % | 1.12 | 40.0 % | +19.0 % | 8 | 0.4 % | 9.0 % | 6.3 | 105.1 % | 7.5 % | 4.6 (11) |
| OPCH Option Care Health Inc | 07/29 | -9 % | 54 5/22 | Stage 4 | C 53 | 3 of 9 | 3.5 $ | Medical Care Facilities | – | — | — | Healthcare | 23.00 $ | -31.0 % | -34.1 % | -21.5 % | −41.6 % | +24.3 % | 11 | 53 | 3.6 % | 3.8 % | 0.65 | 18.3 | 12.3 | 0.6 | 2.7 | 14.9 | 1.23 | 11.0 | 5.4 % | 19.1 % | 3.7 % | 15.3 % | 6.2 % | 0.94 | 40.0 % | +13.0 % | 4 | 0.0 % | 0.0 % | 6.4 | 110.1 % | 11.8 % | 4.5 (10) |
| OI O-I Glass Inc | 08/04 | -18 % | 52 7/31 | Stage 4 | D 29 | 3 of 9 | 1.1 $ | Packaging & Containers | Uses AI | — | Consumer Cyclical | 7.10 $ | -38.4 % | -35.9 % | -45.0 % | −44.4 % | +40.1 % | 11 | 15 | 4.7 % | 4.9 % | 0.63 | — | 12.8 | 0.2 | — | — | 0.35 | 8.6 | 5.7 % | 14.8 % | -18.2 % | -12.1 % | 3.6 % | — | 14.3 % | -1.6 % | 3 | 0.0 % | 0.0 % | 4.1 | 103.9 % | 9.9 % | 4.2 (10) | |
| PRGO Perrigo Company PLC | 08/05 | -22 % | 56 5/22 | Stage 4 | D 27 | 3 of 9 | 1.4 $ | Drug Manufacturers - Specialty & Generic | – | — | — | Healthcare | 10.10 $ | -28.5 % | -23.3 % | -58.9 % | −66.0 % | +63.4 % | 11 | 11 | 5.0 % | 4.9 % | 0.52 | — | 4.7 | 0.3 | 0.6 | 13.1 | 1.14 | 8.4 | 3.5 % | 34.2 % | -43.5 % | -52.2 % | 2.1 % | 1.52 | 31.3 % | -2.8 % | 4 | 11.5 % | 58.0 % | 2.2 | 116.5 % | 25.5 % | 3.8 (5) |
| CWH Camping World Holdings Inc | 08/04 | -24 % | 21 4/31 | Stage 4 | D 44 | 2 of 9 | 0.4 $ | Auto & Truck Dealerships | – | — | — | Consumer Cyclical | 6.20 $ | -25.7 % | -21.7 % | -54.4 % | −61.7 % | +76.4 % | 11 | 87 | 7.7 % | 7.3 % | 2.07 | — | 11.5 | 0.1 | — | 4.9 | 1.70 | 10.3 | — | 28.7 % | -1.6 % | -26.6 % | 1.9 % | — | — | +4.4 % | — | 5.5 % | 272.7 % | 4.4 | 105.7 % | 18.1 % | 4.3 (12) |
| OFIX Orthofix Medical Inc | 08/04 | -17 % | 40 4/22 | Stage 4 | C 53 | 4 of 9 | 0.5 $ | Medical Devices | – | — | — | Healthcare | 11.80 $ | -40.0 % | -36.1 % | +6.9 % | −45.2 % | +31.4 % | 11 | 42 | 4.9 % | 5.6 % | 0.71 | — | 500.0 | 0.6 | — | — | 48.83 | 29.1 | — | 71.0 % | -7.3 % | -13.4 % | -3.3 % | — | — | +2.9 % | 3 | 0.0 % | 0.0 % | 4.7 | 92.1 % | 7.0 % | 4.0 (5) |
| ORGO Organogenesis Holdings Inc | 08/06 | -22 % | 16 2/22 | Stage 4 | C 51 | 2 of 9 | 0.3 $ | Drug Manufacturers - Specialty & Generic | – | — | — | Healthcare | 2.40 $ | -53.1 % | -58.8 % | -48.7 % | −65.7 % | +23.5 % | 11 | 95 | 4.6 % | 5.4 % | 1.33 | — | 12.7 | 0.6 | 1.3 | 17.9 | — | 10.5 | — | 73.9 % | 0.5 % | 0.7 % | 2.1 % | 0.19 | — | +16.8 % | — | 0.0 % | 0.0 % | 8.3 | 49.7 % | 15.0 % | — |
| TCX Tucows Inc. | 08/06 | -17 % | 73 7/25 | Stage 4 | D 37 | 3 of 9 | 0.2 $ | Software - Infrastructure | – | — | — | Technology | 15.40 $ | -39.0 % | -38.1 % | -10.4 % | −47.0 % | +1,024.5 % | 11 | 84 | 4.6 % | 4.4 % | 0.90 | — | 30.5 | 0.4 | — | — | 1.89 | 20.2 | — | 35.0 % | -20.1 % | -1,011.6 % | -1.6 % | — | — | +7.7 % | — | 0.0 % | 0.0 % | 0.3 | 68.6 % | 9.3 % | — |
| COCH Envoy Medical Inc. | 07/30 | -33 % | 93 9/22 | Stage 4 | D 27 | 4 of 9 | 0.1 $ | Medical Devices | – | — | — | Healthcare | 0.67 $ | -1.7 % | -8.8 % | -54.0 % | −64.4 % | +273.1 % | 11 | 42 | 10.6 % | 7.5 % | 1.86 | — | 0.0 | 260.0 | — | — | — | -1.4 | — | -229.5 % | 0.0 % | 0.0 % | -71.3 % | — | — | +7.1 % | — | 0.0 % | 0.0 % | -32.6 | 22.9 % | 2.5 % | — |
| LTBR Lightbridge Corp | 08/10 | +22 % | 24 4/29 | Stage 4 | D 35 | 4 of 9 | 0.3 $ | Electrical Equipment & Parts | – | — | — | Industrials | 8.20 $ | -26.3 % | -39.2 % | -38.9 % | −71.6 % | +17.8 % | 11 | 42 | 6.7 % | 7.4 % | 2.13 | — | 0.0 | — | 1.2 | — | — | -2.4 | — | — | 0.0 % | -15.4 % | -11.6 % | — | — | -100.0 % | — | 0.0 % | 0.0 % | 183.5 | 51.6 % | 13.6 % | — |
| PLCE Children’s Place Inc | — | -32 % | 21 4/31 | Stage 4 | D 26 | 1 of 9 | 0.1 $ | Apparel Manufacturing | – | — | — | Consumer Cyclical | 2.40 $ | -23.4 % | -25.3 % | -49.2 % | −69.1 % | +35.6 % | 11 | 15 | 7.5 % | 9.2 % | 1.95 | — | 6.3 | 0.0 | — | — | 1.42 | 28.2 | — | 29.5 % | -9.1 % | -521.7 % | -5.5 % | — | — | -12.8 % | — | 0.0 % | 0.0 % | 0.5 | 78.8 % | 32.6 % | — |
| SAMG Silvercrest Asset Management Group Inc | 07/30 | -14 % | 30 3/22 | Stage 4 | D 40 | 3 of 9 | 0.1 $ | Asset Management | – | — | — | Financial Services | 10.30 $ | -30.4 % | -29.6 % | -33.2 % | −39.3 % | +93.8 % | 11 | 4 | 6.2 % | 4.1 % | 0.68 | 35.1 | 11.8 | 0.6 | 1.9 | 9.2 | 0.98 | 10.0 | — | 31.2 % | 2.1 % | 4.7 % | 2.5 % | 0.61 | — | +1.4 % | — | 8.0 % | 113.5 % | 6.1 | 68.6 % | 2.4 % | — |
| SBC SBC Medical Group Holdings Incorporated | 08/12 | -23 % | 60 7/29 | Stage 4 | C 52 | 3 of 9 | 0.3 $ | Consulting Services | – | — | — | Industrials | 3.10 $ | -28.8 % | -29.5 % | -29.3 % | −44.7 % | +174.2 % | 11 | 16 | 5.0 % | 4.8 % | 0.59 | 8.0 | 6.6 | 1.9 | 1.3 | 7.4 | — | 2.7 | — | 70.8 % | 24.1 % | 16.5 % | 11.3 % | 0.20 | — | -15.5 % | — | 0.0 % | 0.0 % | 11.8 | 1.4 % | 4.9 % | — |
| TEAM Atlassian Corp Plc | 08/06 | -17 % | 45 5/25 | Stage 4 | C 51 | 4 of 9 | 25.6 $ | Software - Application | – | — | — | Technology | 101.00 $ | -49.8 % | -50.8 % | -47.3 % | −66.5 % | +38.3 % | 10 | 89 | 6.0 % | 7.1 % | 1.11 | — | 15.5 | 4.1 | 29.2 | 21.2 | 0.77 | 2,349.9 | 9.4 % | 84.8 % | -3.5 % | -19.3 % | 0.5 % | -0.87 | 15.6 % | +19.7 % | 8 | 0.0 % | 0.0 % | -1.3 | 108.9 % | 11.1 % | 4.4 (33) |
| DOX Amdocs Ltd | 08/05 | -14 % | 34 4/25 | Stage 4 | C 47 | 4 of 9 | 6.0 $ | Software - Infrastructure | – | — | — | Technology | 55.70 $ | -34.4 % | -35.8 % | -32.5 % | −46.6 % | +45.8 % | 10 | 26 | 3.8 % | 3.4 % | 0.43 | 11.2 | 6.8 | 1.3 | 1.8 | 8.8 | 0.75 | 7.3 | 16.5 % | 37.8 % | 11.8 % | 15.9 % | 8.2 % | 0.32 | 53.2 % | -9.4 % | 4 | 4.1 % | 40.4 % | 9.0 | 100.8 % | 11.4 % | 4.2 (5) |
| ELF ELF Beauty Inc | 08/05 | -14 % | 79 5/16 | Stage 4 | C 50 | 2 of 9 | 4.9 $ | Household & Personal Products | – | — | — | Consumer Defensive | 82.90 $ | -16.5 % | -12.3 % | -31.6 % | −56.9 % | -4.9 % | 10 | 87 | 6.1 % | 6.3 % | 2.39 | 188.4 | 25.1 | 3.0 | 4.4 | 25.6 | 1.37 | 34.3 | 1.7 % | 61.0 % | -0.2 % | -0.3 % | 4.1 % | 0.81 | 47.2 % | +24.6 % | 4 | 0.0 % | 0.0 % | 5.5 | 101.3 % | 15.3 % | 4.2 (17) |
| ACHR Archer Aviation Inc | 08/10 | +18 % | 17 3/29 | Stage 4 | D 33 | 4 of 9 | 3.6 $ | Aerospace & Defense | – | — | — | Industrials | 4.60 $ | -30.2 % | -42.4 % | -53.7 % | −67.2 % | +128.3 % | 10 | 42 | 6.9 % | 7.1 % | 3.19 | — | 0.0 | 1,876.8 | — | — | — | -0.4 | -15,762.5 % | 15.8 % | 0.0 % | -48.1 % | -29.6 % | — | 89.5 % | -100.0 % | 4 | 0.0 % | 0.0 % | 11.8 | 49.2 % | 14.4 % | 4.2 (9) |
| SOUN SoundHound AI Inc | 08/06 | +25 % | 20 3/25 | Stage 4 | D 40 | 2 of 9 | 2.7 $ | Software - Application | – | — | — | Technology | 6.10 $ | -35.4 % | -41.3 % | -40.7 % | −72.0 % | +115.5 % | 10 | 42 | 6.4 % | 6.3 % | 2.81 | — | 227.3 | 14.6 | — | — | — | 135.8 | -139.3 % | 40.6 % | -91.8 % | -39.4 % | -19.7 % | — | 71.4 % | +99.5 % | 3 | 0.0 % | 0.0 % | 1.4 | 44.9 % | 42.4 % | 4.0 (8) |
| COUR Coursera Inc | 07/23 | -19 % | 27 2/16 | Stage 4 | C 53 | 3 of 9 | 1.5 $ | Education & Training Services | – | — | — | Consumer Defensive | 5.30 $ | -26.5 % | -24.1 % | -58.0 % | −57.5 % | +52.0 % | 10 | 42 | 5.5 % | 5.6 % | 1.23 | — | 8.2 | 1.9 | — | 17.8 | — | -7.5 | — | 55.9 % | -15.4 % | -10.3 % | -2.4 % | — | — | +9.0 % | 5 | 0.0 % | 0.0 % | 5.1 | 69.9 % | 8.2 % | 3.7 (15) |
| ONT Onterris | 08/05 | -19 % | — | Stage 4 | C 50 | 3 of 9 | 0.0 $ | Waste Management | – | — | — | Industrials | 21.00 $ | -32.3 % | -22.3 % | -7.5 % | −43.2 % | +50.3 % | 10 | 50 | 6.5 % | 6.3 % | 1.66 | 132.3 | 0.0 | — | 1.6 | — | — | 13.0 | — | 40.4 % | 0.7 % | 1.2 % | 1.1 % | 0.88 | — | +19.3 % | 4 | 0.0 % | 0.0 % | 4.1 | 99.5 % | 9.4 % | — |
| AMPL Amplitude Inc | 08/05 | -12 % | 20 3/25 | Stage 4 | C 49 | 3 of 9 | 1.2 $ | Software - Application | – | — | — | Technology | 8.90 $ | -42.5 % | -36.7 % | -27.4 % | −53.4 % | +27.7 % | 10 | 42 | 6.3 % | 6.6 % | 1.45 | — | 44.1 | 3.3 | — | 52.1 | — | -14.3 | — | 73.6 % | -25.1 % | -35.4 % | -14.1 % | — | — | +14.7 % | 4 | 0.0 % | 0.0 % | -0.1 | 81.5 % | 9.8 % | 3.9 (11) |
| ULH Universal Logistics Holdings Inc | 07/23 | -15 % | 67 8/29 | Stage 4 | D 31 | 3 of 9 | 0.4 $ | Trucking | – | — | — | Industrials | 13.40 $ | -2.4 % | -2.8 % | -42.8 % | −50.5 % | +11.9 % | 10 | 6 | 6.3 % | 6.6 % | 0.69 | — | 11.2 | 0.2 | 0.7 | — | 3.73 | 15.1 | — | 19.1 % | -6.0 % | -18.5 % | 1.2 % | 1.73 | — | -15.6 % | — | 3.1 % | 1.6 % | 4.6 | 28.6 % | 12.7 % | 3.0 (1) |
| JELD Jeld-Wen Holding Inc | 08/04 | -30 % | 23 4/29 | Stage 4 | D 27 | 3 of 9 | 0.1 $ | Building Products & Equipment | – | — | — | Industrials | 1.40 $ | -38.2 % | -43.9 % | -68.4 % | −76.3 % | +18.9 % | 10 | 25 | 12.8 % | 11.4 % | 2.11 | — | 9.3 | 0.0 | 9.9 | — | 2.15 | 74.4 | — | 15.5 % | -16.1 % | -219.2 % | -1.9 % | 115.49 | — | -15.0 % | — | 0.0 % | 0.0 % | 2.5 | 93.0 % | 14.1 % | — |
| LUNG Pulmonx Corp | 07/29 | -30 % | — | Stage 4 | D 34 | 3 of 9 | 0.0 $ | Medical Devices | – | — | — | Healthcare | 1.60 $ | -42.1 % | -41.7 % | -11.4 % | −67.8 % | +172.0 % | 10 | 50 | 8.4 % | 7.8 % | 0.31 | — | 28.3 | — | — | — | — | -5.6 | — | 75.5 % | -60.1 % | -86.2 % | -24.0 % | — | — | +8.0 % | 4 | 0.0 % | 0.0 % | -9.4 | 79.1 % | 6.4 % | — |
| AEYE AudioEye Inc | 08/06 | +3 % | 20 3/25 | Stage 4 | D 41 | 4 of 9 | 0.1 $ | Software - Application | – | — | — | Technology | 5.80 $ | -40.1 % | -47.6 % | -54.8 % | −63.5 % | +163.4 % | 10 | 42 | 7.2 % | 6.7 % | 0.82 | — | 7.0 | 1.6 | 23.4 | 11.4 | 2.16 | 567.8 | — | 78.0 % | -9.0 % | -66.9 % | -7.6 % | 5.33 | — | +14.5 % | — | 0.0 % | 0.0 % | -7.1 | 36.5 % | 5.7 % | — |
| SRTS Sensus Healthcare Inc | 08/06 | -1 % | 83 7/22 | Stage 4 | D 30 | 2 of 9 | 0.0 $ | Medical Devices | – | — | — | Healthcare | 2.90 $ | -31.2 % | -19.3 % | -47.9 % | −50.2 % | +94.9 % | 10 | 94 | 5.3 % | 5.8 % | 1.09 | — | 400.0 | 1.9 | 1.1 | — | — | 12.8 | — | 37.7 % | -34.5 % | -15.8 % | -13.4 % | 0.01 | — | -34.3 % | — | 0.0 % | 0.0 % | 15.0 | 29.1 % | 1.3 % | — |
| TELA Tela Bio Inc | 08/10 | -31 % | 94 9/22 | Stage 4 | D 35 | 4 of 9 | 0.0 $ | Medical Devices | – | — | — | Healthcare | 0.73 $ | -33.4 % | -35.9 % | -57.1 % | −66.4 % | +204.1 % | 10 | 42 | 12.2 % | 11.7 % | 1.34 | — | 0.0 | 0.5 | 7.2 | — | — | -5.0 | — | 67.7 % | -49.3 % | -616.6 % | -28.7 % | -10.84 | — | +15.8 % | 4 | 0.0 % | 0.0 % | -14.8 | 69.0 % | 1.0 % | — |
| VGAS Verde Clean Fuels Inc. | 08/12 | -28 % | 99 8/15 | Stage 4 | D 29 | 2 of 9 | 0.0 $ | Utilities - Renewable | – | — | — | Utilities | 1.00 $ | -22.8 % | -54.1 % | -65.3 % | −59.0 % | — | 10 | 42 | 14.1 % | 10.3 % | -0.32 | — | 0.0 | — | 0.7 | — | — | -0.8 | — | — | 0.0 % | -22.3 % | -11.8 % | 0.02 | — | -100.0 % | — | 0.0 % | 0.0 % | 25.7 | 6.5 % | 3.6 % | — |
| ACM Aecom Technology Corporation | 08/03 | -5 % | 66 8/29 | Stage 4 | C 52 | 4 of 9 | 9.2 $ | Engineering & Construction | – | — | — | Industrials | 72.40 $ | -27.1 % | -27.9 % | -34.9 % | −48.2 % | +37.0 % | 9 | 70 | 3.0 % | 3.4 % | 0.93 | 15.2 | 10.7 | 0.6 | 4.1 | 22.4 | 0.73 | 8.9 | 6.7 % | 7.7 % | 3.2 % | 28.6 % | 5.7 % | 1.47 | 18.9 % | +0.2 % | 5 | 1.6 % | 28.1 % | 4.0 | 93.8 % | 8.5 % | 4.5 (13) |
| AVAV AeroVironment Inc | — | +21 % | 59 7/29 | Stage 4 | C 45 | 2 of 9 | 7.6 $ | Aerospace & Defense | – | — | — | Industrials | 149.40 $ | -38.4 % | -46.7 % | -44.2 % | −67.3 % | +51.1 % | 9 | 89 | 5.4 % | 6.4 % | 1.40 | — | 47.6 | 4.7 | 1.8 | — | 1.57 | 69.6 | -5.1 % | 25.3 % | -13.4 % | -8.7 % | -1.3 % | 0.46 | 77.0 % | +14.5 % | 3 | 0.0 % | 0.0 % | 8.5 | 89.2 % | 10.1 % | 4.4 (19) |
| G Genpact Limited | 08/06 | -6 % | 61 6/25 | Stage 4 | C 53 | 2 of 9 | 5.9 $ | Information Technology Services | – | — | — | Technology | 35.20 $ | -38.9 % | -41.5 % | -18.7 % | −43.1 % | +11.6 % | 9 | 64 | 4.4 % | 4.2 % | 0.62 | 11.1 | 18.3 | 1.1 | 2.5 | 9.0 | 1.16 | 7.4 | 15.4 % | 36.3 % | 11.0 % | 23.1 % | 9.2 % | 2.49 | 44.1 % | +6.6 % | 5 | 2.1 % | 24.5 % | 7.0 | 109.3 % | 10.5 % | 3.9 (11) |
| VSTM Verastem Inc | 08/06 | -17 % | 40 4/22 | Stage 4 | D 35 | 3 of 9 | 0.5 $ | Biotechnology | – | — | — | Healthcare | 5.80 $ | -45.5 % | -51.5 % | -6.0 % | −69.3 % | +158.6 % | 9 | 42 | 8.6 % | 7.4 % | 0.29 | — | 0.0 | 10.3 | 6.8 | — | — | -0.2 | — | 85.1 % | 0.0 % | -786.2 % | -59.4 % | 1.05 | — | +209.1 % | 4 | 0.0 % | 0.0 % | -15.1 | 93.6 % | 23.0 % | 4.8 (9) |
| NIQ NIQ Global Intelligence plc | 08/13 | — | — | Stage 4 | C 49 | — | 0.0 $ | — | – | — | — | — | 11.20 $ | -50.9 % | -47.8 % | -39.4 % | −60.9 % | +81.4 % | 9 | 50 | 5.4 % | 5.7 % | — | — | 9.7 | — | — | — | — | 8.3 | — | — | 0.0 % | 0.0 % | 0.0 % | — | — | — | — | 0.0 % | 0.0 % | — | 0.0 % | — | — |
| EU enCore Energy Corp. Common Shares | 08/10 | -13 % | — | Stage 4 | D 43 | 4 of 9 | 0.0 $ | Uranium | – | — | — | Energy | 1.10 $ | -40.3 % | -46.8 % | -58.7 % | −68.2 % | +184.9 % | 9 | 50 | 8.7 % | 8.2 % | 1.27 | — | 10.9 | — | — | — | — | -49.7 | — | -43.3 % | -63.0 % | -12.1 % | -11.5 % | — | — | +1.5 % | 3 | 0.0 % | 0.0 % | 4.7 | 50.9 % | 13.5 % | — |
| ALT Altimmune Inc | 08/11 | -9 % | 15 2/22 | Stage 4 | D 42 | 3 of 9 | 0.6 $ | Biotechnology | – | — | — | Healthcare | 2.80 $ | -19.4 % | -26.1 % | -23.0 % | −62.9 % | +515.1 % | 9 | 42 | 5.4 % | 4.7 % | 0.24 | — | 8.2 | — | — | — | 32.62 | 11.9 | — | -183,477.8 % | 0.0 % | -42.8 % | -24.4 % | — | — | +105.0 % | 3 | 0.0 % | 0.0 % | 7.1 | 57.8 % | 24.8 % | 4.4 (9) |
| LAB Standard Biotools Inc | 08/10 | -20 % | — | Stage 4 | D 27 | 3 of 9 | 0.0 $ | Medical Devices | – | — | — | Healthcare | 0.87 $ | -38.1 % | -49.2 % | -34.6 % | −57.0 % | +109.5 % | 9 | 50 | 8.1 % | 8.3 % | 1.42 | — | 0.0 | — | 0.6 | — | — | -19.2 | — | 53.3 % | 90.7 % | -9.9 % | -8.1 % | 0.05 | — | -51.1 % | 3 | 0.0 % | 0.0 % | 9.0 | 76.7 % | 4.2 % | — |
| CVRX CVRx Inc | 08/03 | -21 % | 89 8/22 | Stage 4 | D 37 | 3 of 9 | 0.1 $ | Medical Devices | – | — | — | Healthcare | 5.20 $ | -27.5 % | -22.7 % | -35.0 % | −53.5 % | +112.7 % | 9 | 42 | 6.8 % | 7.0 % | 0.78 | — | 0.0 | 2.4 | — | — | — | -1.3 | — | 86.2 % | -89.1 % | -107.0 % | -27.3 % | — | — | +10.5 % | — | 0.0 % | 0.0 % | -13.5 | 63.6 % | 9.3 % | — |
| CCLD CareCloud, Inc. | 08/04 | -21 % | 57 5/22 | Stage 4 | C 52 | 4 of 9 | 0.1 $ | Health Information Services | – | — | — | Healthcare | 2.40 $ | -24.3 % | -30.1 % | +2.5 % | −48.1 % | +194.5 % | 9 | 98 | 4.6 % | 4.9 % | 1.52 | 19.1 | 6.3 | 0.8 | 1.8 | 3.7 | 0.31 | 3.5 | — | 47.0 % | 7.9 % | 17.4 % | 8.1 % | 0.10 | — | +8.7 % | — | 0.0 % | 0.0 % | 4.4 | 28.8 % | 0.9 % | — |
| CRGO Freightos Limited Ordinary shares | 08/17 | -20 % | 60 7/29 | Stage 4 | C 53 | 3 of 9 | 0.1 $ | Integrated Freight & Logistics | – | — | — | Industrials | 1.20 $ | -36.8 % | -40.7 % | -58.9 % | −67.9 % | +105.9 % | 9 | 42 | 6.7 % | 7.6 % | 1.16 | — | 0.0 | 2.0 | 1.7 | — | — | -1.1 | — | 66.8 % | -65.6 % | -43.8 % | -18.4 % | 0.06 | — | +23.9 % | — | 0.0 % | 0.0 % | -8.5 | 26.0 % | 0.6 % | — |
| MCRB Seres Therapeutics Inc | 08/05 | -31 % | 57 5/22 | Stage 4 | D 28 | 3 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 4.80 $ | -52.6 % | -49.1 % | -66.1 % | −77.2 % | +148.5 % | 9 | 3 | 11.2 % | 9.5 % | 0.10 | — | 10.8 | 40.0 | — | — | — | 7.9 | — | -4,560.1 % | 0.0 % | -121.9 % | -38.9 % | — | — | -100.0 % | — | 0.0 % | 0.0 % | -25.9 | 24.4 % | 3.0 % | — |
| NTHI NeOnc Technologies Holdings, Inc. Common Stock | 08/17 | — | 97 10/22 | Stage 4 | E 20 | 3 of 9 | 0.1 $ | Biotechnology | Uses AI | — | Healthcare | 3.50 $ | -41.0 % | -46.9 % | -28.8 % | −65.3 % | +254.8 % | 9 | 42 | 10.7 % | 9.8 % | — | — | 0.0 | — | 0.0 | — | — | 0.0 | — | — | 0.0 % | 0.0 % | -354.6 % | -0.03 | — | -51.8 % | — | 0.0 % | 0.0 % | -188.6 | 11.1 % | 2.5 % | — | |
| SPWH Sportsmans | — | -29 % | 52 7/31 | Stage 4 | D 38 | 4 of 9 | 0.0 $ | Specialty Retail | – | — | — | Consumer Cyclical | 1.10 $ | -15.1 % | -3.6 % | -66.2 % | −68.5 % | +139.1 % | 9 | 7 | 6.3 % | 6.4 % | 0.41 | — | 333.3 | 0.0 | 0.3 | 3.3 | 0.88 | 284.4 | — | 30.7 % | -4.2 % | -26.5 % | -0.9 % | 2.89 | — | +1.0 % | — | 0.0 % | 0.0 % | 4.0 | 60.3 % | 0.9 % | — |
| VTGN VistaGen Therapeutics Inc | 08/06 | -32 % | 42 4/22 | Stage 4 | D 43 | 3 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 0.24 $ | -4.2 % | +4.1 % | -91.6 % | −88.0 % | +61.3 % | 9 | 42 | 13.8 % | 9.8 % | 0.40 | — | 0.0 | 9.2 | 0.3 | — | — | -0.2 | — | 100.0 % | 0.0 % | -131.6 % | -67.8 % | 0.03 | — | +161.1 % | 3 | 0.0 % | 0.0 % | -31.0 | 40.8 % | 4.2 % | — |
| KMPR Kemper Corporation | 08/04 | -14 % | 26 3/22 | Stage 4 | D 40 | 3 of 9 | 1.7 $ | Insurance - Property & Casualty | – | — | — | Financial Services | 28.40 $ | -34.0 % | -32.0 % | -52.3 % | −61.0 % | +79.6 % | 8 | 30 | 4.1 % | 4.3 % | 1.03 | — | 5.0 | 0.4 | — | 3.6 | 0.75 | 0.0 | 0.8 % | 27.0 % | 0.9 % | 1.1 % | 0.5 % | — | 21.3 % | +3.6 % | 2 | 4.5 % | 1.6 % | — | 93.2 % | 9.8 % | 4.3 (6) |
| WGS GeneDx Holdings Corp. | 08/04 | +283 % | 39 4/22 | Stage 4 | D 40 | 2 of 9 | 1.9 $ | Diagnostics & Research | – | — | — | Healthcare | 65.10 $ | -55.3 % | -49.2 % | -36.1 % | −59.8 % | +25.6 % | 8 | 42 | 7.9 % | 8.0 % | 1.91 | — | 204.1 | 4.2 | 7.7 | — | — | 161.2 | — | 69.6 % | -17.6 % | -30.4 % | -4.4 % | 0.66 | — | +40.0 % | 8 | 0.0 % | 0.0 % | -3.6 | 114.7 % | 37.8 % | 4.7 (6) |
| CERT Certara Inc | 08/05 | -23 % | 56 5/22 | Stage 4 | D 30 | 4 of 9 | 1.2 $ | Health Information Services | – | — | — | Healthcare | 8.10 $ | -38.7 % | -28.6 % | -17.7 % | −60.5 % | -7.0 % | 8 | 25 | 7.8 % | 6.6 % | 1.46 | — | 12.7 | 3.0 | 1.2 | 14.0 | — | 15.6 | — | 61.6 % | -3.6 % | -1.4 % | 0.8 % | 0.30 | — | +8.8 % | 6 | 0.0 % | 0.0 % | 5.9 | 112.6 % | 29.6 % | 3.8 (11) |
| PTLO Portillo's Inc | 08/04 | -27 % | 21 4/31 | Stage 4 | C 46 | 3 of 9 | 0.3 $ | Restaurants | – | — | — | Consumer Cyclical | 4.60 $ | -10.6 % | +0.2 % | -54.1 % | −64.4 % | +36.4 % | 8 | 14 | 5.8 % | 5.3 % | 1.57 | — | 25.4 | 0.4 | — | — | — | 14.1 | — | 21.2 % | 2.1 % | 3.3 % | 1.8 % | — | — | +3.0 % | — | 0.0 % | 0.0 % | 3.4 | 76.4 % | 15.0 % | 4.1 (10) |
| JRVR James River Group Holdings Ltd | 08/03 | -26 % | 70 6/22 | Stage 4 | D 29 | 1 of 9 | 0.2 $ | Insurance - Specialty | – | — | — | Financial Services | 4.50 $ | -36.5 % | -30.1 % | -20.6 % | −44.0 % | +33.4 % | 8 | 13 | 4.7 % | 4.3 % | -0.19 | 10.7 | 6.0 | 0.3 | 0.4 | 7.6 | — | 0.0 | — | 34.6 % | 4.3 % | 4.7 % | 0.6 % | 0.51 | — | -2.8 % | — | 0.9 % | 4.9 % | 2.7 | 81.3 % | 3.3 % | — |
| ALDX Aldeyra Therapeutics, Inc. | 08/06 | -24 % | 70 6/22 | Stage 4 | C 47 | 1 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 1.50 $ | -61.0 % | -61.2 % | -69.1 % | −70.9 % | +322.2 % | 8 | 42 | 9.5 % | 8.5 % | 1.15 | — | 0.0 | — | 2.1 | — | — | 7.0 | — | — | 0.0 % | -51.8 % | -22.2 % | 0.37 | — | — | — | 0.0 % | 0.0 % | -17.3 | 62.8 % | 11.8 % | — |
| BDTX Black Diamond Therapeutics Inc | 08/06 | -25 % | 16 2/22 | Stage 4 | E 20 | 1 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 1.70 $ | -33.7 % | -34.5 % | -36.5 % | −65.6 % | +479.8 % | 8 | 42 | 8.1 % | 9.6 % | 3.25 | — | 8.3 | — | 0.9 | — | — | 2.6 | — | — | 0.0 % | -35.2 % | -18.6 % | 0.17 | — | — | — | 0.0 % | 0.0 % | -1.1 | 78.6 % | 12.5 % | — |
| CRVO CervoMed Inc. | 08/14 | -28 % | 16 2/22 | Stage 4 | D 25 | 1 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 2.60 $ | -52.9 % | -79.6 % | -68.7 % | −74.5 % | +482.1 % | 8 | 42 | 21.8 % | 12.8 % | -4.42 | — | 0.0 | 10.0 | 2.4 | — | — | 1.6 | — | -958.5 % | 0.0 % | -132.8 % | -72.4 % | — | — | -58.9 % | 4 | 0.0 % | 0.0 % | -18.8 | 13.3 % | 5.4 % | — |
| CURI Curiositystream Inc. | 08/04 | +74 % | 50 5/24 | Stage 4 | D 43 | 4 of 9 | 0.1 $ | Broadcasting | – | — | — | Communication Services | 2.40 $ | -31.3 % | -27.6 % | -45.2 % | −58.5 % | +118.6 % | 8 | 42 | 5.5 % | 7.0 % | 1.77 | — | 26.4 | 2.0 | — | 11.9 | — | 26.3 | — | 57.2 % | -11.3 % | -17.1 % | -7.2 % | — | — | +40.1 % | — | 11.7 % | 0.0 % | -12.6 | 33.3 % | 5.9 % | — |
| FKWL Franklin Wireless Corp | — | -9 % | 87 9/25 | Stage 4 | D 38 | 4 of 9 | 0.0 $ | Communication Equipment | – | — | — | Technology | 2.30 $ | -41.4 % | -36.5 % | -40.9 % | −53.8 % | +137.2 % | 8 | 88 | 3.7 % | 4.3 % | 0.27 | — | 27.2 | 0.8 | 0.8 | — | — | -10.4 | — | 19.3 % | -2.1 % | -2.2 % | -2.7 % | 0.03 | — | +49.7 % | 7 | 0.8 % | 0.0 % | 11.3 | 15.7 % | 0.3 % | — |
| PEPG PepGen Ltd | 08/06 | -31 % | 83 7/22 | Stage 4 | D 32 | 4 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 1.80 $ | -72.0 % | -69.2 % | +28.5 % | −78.1 % | +499.4 % | 8 | 42 | 7.6 % | 6.9 % | 1.88 | — | 0.0 | — | — | — | — | -3.1 | — | — | 0.0 % | -68.4 % | -35.8 % | — | — | — | — | 0.0 % | 0.0 % | 3.5 | 90.2 % | 7.9 % | — |
| PETS PetMed Express Inc | — | -29 % | 42 4/22 | Stage 4 | E 21 | 3 of 9 | 0.0 $ | Pharmaceutical Retailers | – | — | — | Healthcare | 2.00 $ | -42.8 % | -48.7 % | -37.5 % | −56.8 % | +21.5 % | 8 | 92 | 6.3 % | 5.9 % | 0.78 | — | 16.7 | 0.2 | — | — | 2.32 | 3.5 | — | 28.1 % | -32.0 % | -100.4 % | -15.4 % | — | — | -34.7 % | — | 0.0 % | 0.0 % | 1.5 | 44.8 % | 3.9 % | — |
| RMTI Rockwell Medical Inc | 08/13 | -28 % | 58 5/22 | Stage 4 | D 26 | 4 of 9 | 0.0 $ | Drug Manufacturers - Specialty & Generic | – | — | — | Healthcare | 7.20 $ | -19.9 % | -27.4 % | -22.7 % | −69.0 % | +4,515.4 % | 8 | 42 | 6.4 % | 5.9 % | 1.62 | — | 33.0 | 0.5 | 0.8 | 18.3 | 4.43 | 22.1 | — | 17.1 % | -8.0 % | -16.0 % | -5.4 % | 0.40 | — | -31.8 % | 2 | 0.0 % | 0.0 % | -15.4 | 10.1 % | 1.9 % | — |
| SIEB Siebert Financial Corp | 08/11 | -8 % | 3 0/22 | Stage 4 | E 22 | 1 of 9 | 0.1 $ | Capital Markets | – | — | — | Financial Services | 1.60 $ | -46.7 % | -55.1 % | -60.0 % | −60.0 % | — | 8 | 12 | 7.3 % | 6.9 % | 0.91 | — | 38.3 | 0.8 | 0.6 | 3.1 | 0.72 | 31.7 | — | 90.6 % | -6.3 % | -6.0 % | -1.0 % | 0.13 | — | +17.0 % | — | 0.0 % | 0.0 % | 4.3 | 8.0 % | 3.0 % | — |
| SKYE Skye Bioscience, Inc. | 08/06 | -29 % | 58 5/22 | Stage 4 | E 18 | 2 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 0.57 $ | -6.7 % | -19.6 % | -84.1 % | −87.7 % | +986.5 % | 8 | 42 | 7.9 % | 8.1 % | 2.94 | — | 0.0 | — | — | — | — | -2.6 | — | — | 0.0 % | -168.0 % | -87.7 % | — | — | +1,992.8 % | 3 | 0.0 % | 0.0 % | -46.4 | 46.0 % | 3.9 % | — |
| VTSI VirTra Inc | 08/10 | -19 % | 62 6/25 | Stage 4 | D 29 | 2 of 9 | 0.0 $ | Software - Application | – | — | — | Technology | 3.10 $ | -22.6 % | -28.6 % | -56.4 % | −58.1 % | +99.7 % | 8 | 5 | 4.4 % | 4.8 % | 0.73 | — | 22.0 | 2.1 | 0.8 | 100.0 | 0.69 | 14.5 | — | 64.9 % | -12.5 % | -5.1 % | -2.2 % | 0.17 | — | -15.0 % | 5 | 0.0 % | 0.0 % | 9.0 | 17.4 % | 0.7 % | — |
Price Chart
Quarterly Figures
No quarterly data available.
Frequently Asked Questions
Stage 4 + very weak RS (≤ 15) + price below the 200-day SMA — multiple weakness signals bundled together.
All scanners are recalculated daily across the entire stock universe — most recently on 3. August 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).
Currently, 210 stocks pass this scanner's criteria (as of 3. August 2026). The 100 strongest hits are shown.
Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); fundamentally healthy names (Piotroski ≥ 5 or Fundamental Rating ≥ 55 out of 100) are excluded.
This scanner deliberately hunts for red flags — a hit is a finding, not a recommendation: like a smoke detector that beeps so you look in time. A hit is also not a bankruptcy verdict; most companies save themselves (say, through a capital raise, which dilutes existing shareholders). Portfolio owners use the list as an early-warning system, bargain hunters as an anti-shopping list, experienced traders as a watch list — it is never a buy or short recommendation.
Related scanners
- Altman Z: Distress Zone
- Bankruptcy Study: Stacked Warning Signals
- Below the 50- & 200-SMA
- Beneish M-Score
- Downward Momentum
- Going Concern (Distress Proxy)
- Insolvency Radar: Cash Running Low
- Kathy Donnelly: Liquid Movers Down
- Mike Webster: Overextended (Webby RSI)
- Near 52-Week Low
- Pradeep Bonde: $ Breakout Bearish
- Pradeep Bonde: 4% Breakout Bearish
- Qullamaggie: Parabolic (Short-Watch)
- RS Weakness (≤10)
- Stage 4 (Downtrend)
- Stan Weinstein: Stage 4
- Stan Weinstein: Stage 4B-
- Thomas Insolvency Candidate
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.